Effect of guideline revisions by the Swiss Society of Hypertension on blood pressure control in hypertensive patients from primary care

被引:0
|
作者
Stephanie, Giezendanner [1 ]
Peter, Tschudi [1 ]
Jorg, Leuppi [2 ]
Thomas, Dieterle [2 ]
Andreas, Zeller [1 ]
机构
[1] Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland
[2] Cantonal Hosp Baselland, Univ Dept Med, Liestal, Switzerland
关键词
guidelines; hypertension; complicated hypertension; blood pressure target; diabetes mellitus; renal dysfunction; prospective cohort study; 2013 ESH/ESC GUIDELINES; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR RISK; CLINICAL GUIDELINES; GENERAL-POPULATION; HIGH PREVALENCE; MANAGEMENT; MORTALITY; COUNTRIES; TARGETS;
D O I
10.4414/smw.2020.20279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Recommendations for blood pressure goals have considerably changed across time, in particular for high-risk patients with diabetes mellitus and/or renal dysfunction. Before 2009, Swiss Society of Hypertension (SSH) guidelines recommended lowering blood pressure to <135/85 mm Hg and after 2009 to <130/80 mm Hg in high-risk patients. It remains unclear whether guideline changes for blood pressure targets are associated with reductions in blood pressure in hypertensive patients treated in primary care. The objective was to report the association between guideline change and blood pressure target achievement, as well as the prevalence of blood pressure target achievement according to guidelines and to identify factors associated with blood pressure target achievement in a Swiss primary care sample of treated hypertensive patients. METHODS: We used longitudinal data from the Swiss Hypertension Cohort Study, which was a prospective, observational study conducted by the Centre for Primary Health Care of the University of Basel from 2006 to 2013. General practitioners (GPs) enrolled 1003 patients attending their practice with a pre-existing diagnosis of arterial hypertension or office blood pressure measurement >= 140/90 mm Hg and assessed office blood pressure, cardiovascular risk factors, subclinical organ damage, diabetes mellitus, and established cardiovascular and renal disease. Mixed-effects regression models were used to estimate the associations of (1) the change in hypertension guidelines in 2009 with blood pressure and antihypertensive therapy in high-risk patients, and (2) cardiovascular risk factors with blood pressure target achievement in patients with complicated and uncomplicated hypertension. Models were adjusted for sociodemographic and health-related covariates. Missing data were imputed using a "multiple imputation by chained equation" approach. RESULTS: At baseline, hypertensive patients were on average 65.9 +/- 12.5 years old and 55% were male. Blood pressure targets were achieved in 47% of patients with uncomplicated hypertension and in 13% of high-risk patients at baseline. In multivariable analyses adjusted for potential confounding factors, a visit by high-risk patients after 2009 was associated with decreased systolic office blood pressure (-5.40 mm Hg, 95% confidence interval [CI] -8.08 to 2.73) and a trend towards an increased use of pharmacological combination therapy (odds ratio [OR] 1.85, 95% CI 0.94 to 3.63; p = 0.073) compared with a visit before 2009. Neither a reduction of diastolic blood pressure nor an increase of blood pressure target achievement in high-risk patients was observed after 2009. High-risk patients were slightly more likely to achieve blood pressure targets at later follow-up visits than at baseline (OR 1.35, 95% CI 0.98 to 1.86; p = 0.068). In patients with uncomplicated hypertension, factors associated with the likelihood to achieve blood pressure goals were the increased use of pharmacological combination therapy (OR 1.19 per combination increase: e.g., dual therapy vs monotherapy, 95% CI 1.02 to 1.40), left ventricular hypertrophy (OR 0.58, 95% CI 0.36 to 0.93), older age (OR 1.19 per 10 years, 95% CI 1.02 to 1.40) and the number of follow-up examinations (OR 1.44 per follow-up visit, 95% CI 1.21 to 1.72). CONCLUSION: Overall, blood pressure goal attainment remains low for treated hypertensive patients followed up by primary care physicians in Switzerland. Independent of known confounding factors for blood pressure, the 2009 guideline change in high-risk patients was associated with a reduction in systolic office blood pressure together with an increase in pharmacological combination therapy. These results highlight primary care physicians' efforts to implement blood pressure guidelines. Further, blood pressure goal attainment was more likely to be achieved in later follow-up visits, indicating that it takes time and regular follow-up visits with the GP to meet blood pressure goals.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] The prognostic value of blood pressure control delay in newly diagnosed hypertensive patients
    Martin-Fernandez, Miguel
    Vinyoles, Ernest
    Real, Jordi
    Soldevila, Nuria
    Munoz, Miguel-Angel
    Luis Del-Val, Jose
    Maria Verdu, Jose
    Domingo, Mar
    Mundet, Xavier
    JOURNAL OF HYPERTENSION, 2019, 37 (02) : 426 - 431
  • [42] Effect of Intensive Blood Pressure Control and Comorbidity Status on the Prognosis of Patients With Hypertension: Insights From SPRINT
    Zheng, Wen
    Li, Siyi
    Jiang, Chao
    Hao, Wen
    Ai, Hui
    Wang, Xiao
    Ma, Changsheng
    Nie, Shaoping
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (06):
  • [43] Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study
    Grassi, Guido
    Cifkova, Renata
    Laurent, Stephane
    Narkiewicz, Krzysztof
    Redon, Joseph
    Farsang, Csaba
    Viigimaa, Margus
    Erdine, Serap
    Brambilla, Gianmaria
    Bombelli, Michele
    Dell'Oro, Raffaella
    Notari, Massimo
    Mancia, Giuseppe
    EUROPEAN HEART JOURNAL, 2011, 32 (02) : 218 - 225
  • [44] Cardiovascular risk stratification in primary care patients with arterial hypertension: Results from the Swiss Hypertension Cohort Study (HccH)
    Handschin, Anja
    Brighenti-Zogg, Stefanie
    Mundwiler, Jonas
    Giezendanner, Stephanie
    Gregoriano, Claudia
    Martina, Benedict
    Tschudi, Peter
    Leuppi, Joerg D.
    Zeller, Andreas
    Dieterle, Thomas
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (17) : 1843 - 1851
  • [45] The effect of blood pressure variability on the prognosis of hypertensive patients
    Taher, Ziad A.
    Khayyat, Waleed W.
    Balubaid, Marwan M.
    Tashkandi, Mohamed Y.
    Khayyat, Haifaa Akif
    Kinsara, Abdulhalim Jamal
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2019, 22 (03) : 112 - 116
  • [46] Hypertension management in older patients-Are the guideline blood pressure targets appropriate?
    Masoli, Jane A. H.
    Sheppard, James P.
    Rajkumar, Chakravarthi
    AGE AND AGEING, 2022, 51 (01)
  • [47] Determinants of masked hypertension in hypertensive patients treated in a primary care setting
    Andalib, A.
    Akhtari, S.
    Rigal, R.
    Curnew, G.
    Leclerc, J. -M.
    Vaillancourt, M.
    Tardif, J. -C.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (03) : 260 - 266
  • [48] Pharmacological therapy and blood pressure control in primary health care sites in China: data from 254,848 hypertensive patients
    Hou, Lei
    Chen, Xiaorong
    Chen, Bo
    Liu, Longjian
    Sun, Xiaohui
    Zou, Yuewei
    Liu, Hongjian
    Guo, Hui
    Zhang, Jian
    Ma, Jixiang
    CLINICAL EPIDEMIOLOGY, 2018, 10 : 1467 - 1478
  • [49] Validity of self-reported blood pressure control in people with hypertension attending a primary care center
    Gee, Marianne E.
    Pickett, William
    Janssen, Ian
    Campbell, Norm R. C.
    Birtwhistle, Richard
    BLOOD PRESSURE MONITORING, 2014, 19 (01) : 19 - 25
  • [50] Diabetes mellitus in hypertensive population attended in Primary Care in Spain.: Blood pressure and lipid control rates
    Escobar, C.
    Barrios, V.
    Calderon, A.
    Llisterri, J. L.
    Garcia, S.
    Rodriguez-Roca, G. C.
    Matali, A.
    REVISTA CLINICA ESPANOLA, 2007, 207 (05): : 221 - 227